SISCAPA Assay Technologies
Dr. Razavi obtained his B.Sc. in microbiology and his Ph.D. in Biochemistry from the University of Victoria with a focus on clinical proteomics. In his role as Director of Lab Operations, Morty has designed a fully automated SISCAPA workflow suitable for high throughput clinical settings that is compatible with whole blood, plasma, serum and dried blood spot specimens. His primary current focus is to develop diagnostic panels for longitudinal monitoring of health and disease using a single drop of blood. Morty believes that improved, individualized diagnostics will allow personalized medicine to reach its full potential and become widely accessible as a result of his work.
This person is not in any offices
SISCAPA Assay Technologies
SISCAPA technology is the smart shortcut to the sensitive quantitation of protein biomarkers and targets. SISCAPA assays combine the precision of MRM mass spectrometry with the power of affinity enrichment to deliver a superior alternative to conventional immunoassays for protein quantitation.